Hua Medicine (Shanghai) Ltd. 2552.HK Stock
Hua Medicine (Shanghai) Ltd. Price Chart
Hua Medicine (Shanghai) Ltd. 2552.HK Financial and Trading Overview
Hua Medicine (Shanghai) Ltd. stock price | 1.51 HKD |
Previous Close | 1.96 HKD |
Open | 1.95 HKD |
Bid | 2 HKD x 0 |
Ask | 2.03 HKD x 0 |
Day's Range | 1.95 - 2.17 HKD |
52 Week Range | 1.75 - 5.02 HKD |
Volume | 2.07M HKD |
Avg. Volume | 1.41M HKD |
Market Cap | 1.94B HKD |
Beta (5Y Monthly) | 1.438874 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.24 HKD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.48 HKD |
2552.HK Valuation Measures
Enterprise Value | 1.51B HKD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 110.24615 |
Price/Book (mrq) | 6.9444447 |
Enterprise Value/Revenue | 85.708 |
Enterprise Value/EBITDA | -5.919 |
Trading Information
Hua Medicine (Shanghai) Ltd. Stock Price History
Beta (5Y Monthly) | 1.438874 |
52-Week Change | -45.098% |
S&P500 52-Week Change | 20.43% |
52 Week High | 5.02 HKD |
52 Week Low | 1.75 HKD |
50-Day Moving Average | 2.71 HKD |
200-Day Moving Average | 3.41 HKD |
2552.HK Share Statistics
Avg. Volume (3 month) | 1.41M HKD |
Avg. Daily Volume (10-Days) | 1.21M HKD |
Shares Outstanding | 970.11M |
Float | 620.01M |
Short Ratio | N/A |
% Held by Insiders | 24.79% |
% Held by Institutions | 32.51% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -1517.80% |
Gross Margin | 43.68% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -16.48% |
Return on Equity (ttm) | -55.76% |
Income Statement
Revenue (ttm) | 17.6M HKD |
Revenue Per Share (ttm) | 0.02 HKD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | 7.69M HKD |
EBITDA | -254818000 HKD |
Net Income Avi to Common (ttm) | -203507008 HKD |
Diluted EPS (ttm) | -0.25 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 490.63M HKD |
Total Cash Per Share (mrq) | 0.51 HKD |
Total Debt (mrq) | 97.58M HKD |
Total Debt/Equity (mrq) | 34.9 HKD |
Current Ratio (mrq) | 4.991 |
Book Value Per Share (mrq) | 0.288 |
Cash Flow Statement
Operating Cash Flow (ttm) | -230114000 HKD |
Levered Free Cash Flow (ttm) | -524532640 HKD |
Profile of Hua Medicine (Shanghai) Ltd.
Country | Hong Kong |
State | N/A |
City | Beijing |
Address | Building A |
ZIP | N/A |
Phone | N/A |
Website | https://www.huamedicine.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 144 |
Hua Medicine (Shanghai) Ltd. operates as a drug development company that focuses on therapies for the treatment of diabetes in China. It develops Dorzagliatin or HMS5552, an oral drug for the treatment of Type 2 Diabetes (T2D); and Dorzagliatin in combination with Metformin, Sitagliptin, and Empagliflozin for treatment of T2D. The company also offers Dorzagliatin in combination with Pioglitazone for NASH; in combination with GLP-1 for Alzheimer diseases; and in combination with insulin for late stage T2D and Type 1 Diabetes. In addition, it is developing mGLUR5 for the treatment of Parkinson's disease; and Fructokinase Inhibitor for Metabolic disease. The company was incorporated in 2011 and is based in Beijing, China.
Q&A For Hua Medicine (Shanghai) Ltd. Stock
What is a current 2552.HK stock price?
Hua Medicine (Shanghai) Ltd. 2552.HK stock price today per share is 1.51 HKD.
How to purchase Hua Medicine (Shanghai) Ltd. stock?
You can buy 2552.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hua Medicine (Shanghai) Ltd.?
The stock symbol or ticker of Hua Medicine (Shanghai) Ltd. is 2552.HK.
Which industry does the Hua Medicine (Shanghai) Ltd. company belong to?
The Hua Medicine (Shanghai) Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Hua Medicine (Shanghai) Ltd. have in circulation?
The max supply of Hua Medicine (Shanghai) Ltd. shares is 978.72M.
What is Hua Medicine (Shanghai) Ltd. Price to Earnings Ratio (PE Ratio)?
Hua Medicine (Shanghai) Ltd. PE Ratio is now.
What was Hua Medicine (Shanghai) Ltd. earnings per share over the trailing 12 months (TTM)?
Hua Medicine (Shanghai) Ltd. EPS is -0.24 HKD over the trailing 12 months.
Which sector does the Hua Medicine (Shanghai) Ltd. company belong to?
The Hua Medicine (Shanghai) Ltd. sector is Healthcare.
Hua Medicine (Shanghai) Ltd. 2552.HK included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}